Coronavirus Update: Lilly’s Antibody EUA Adds To ‘Turnaround’ Hopes On Pandemic

First Antibody Therapy EUA

 
• By Scrip Team
  
Eli Lilly
Lilly is the first to gain an EUA for its antibody therapy, but Regeneron looks likely to be not far behind.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip